Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Leases: 2022-2023

Historic Leases for Cullinan Therapeutics (CGEM) over the last 2 years, with Sep 2023 value amounting to $2.9 million.

  • Cullinan Therapeutics' Leases fell 34.94% to $2.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.9 million, marking a year-over-year decrease of 34.94%. This contributed to the annual value of $4.1 million for FY2022, which is N/A change from last year.
  • According to the latest figures from Q3 2023, Cullinan Therapeutics' Leases is $2.9 million, which was down 16.45% from $3.5 million recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Leases ranged from a high of $4.5 million in Q3 2022 and a low of $1.1 million during Q2 2022.
  • Its 2-year average for Leases is $3.0 million, with a median of $3.5 million in 2023.
  • Data for Cullinan Therapeutics' Leases shows a peak YoY increase of 225.98% (in 2023) and a maximum YoY decrease of 34.94% (in 2023) over the last 5 years.
  • Cullinan Therapeutics' Leases (Quarterly) stood at $4.1 million in 2022, then crashed by 34.94% to $2.9 million in 2023.
  • Its Leases was $2.9 million in Q3 2023, compared to $3.5 million in Q2 2023 and $3.8 million in Q1 2023.